These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17963419)

  • 1. Modeling the impact of genetic screening technologies on healthcare: theoretical model for asthma in children.
    Gutiérrez de Mesa E; Hidalgo I; Christidis P; Ciscar JC; Vegas E; Ibarreta D
    Mol Diagn Ther; 2007; 11(5):313-23. PubMed ID: 17963419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach.
    Hofer F; Kauczor HU; Stargardt T
    Lung Cancer; 2018 Oct; 124():189-198. PubMed ID: 30268459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
    Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
    Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a population-based AAA screening program for men over 65 years old in Iran.
    Daroudi R; Shafe O; Moosavi J; Salimi J; Bayazidi Y; Zafarghandi MR; Maleki M; Moini M; Farshidmehr P; Sadeghipour P
    Cost Eff Resour Alloc; 2021 May; 19(1):29. PubMed ID: 33985531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF.
    van Heesch MM; van Asselt AD; Evers JL; van der Hoeven MA; Dumoulin JC; van Beijsterveldt CE; Bonsel GJ; Dykgraaf RH; van Goudoever JB; Koopman-Esseboom C; Nelen WL; Steiner K; Tamminga P; Tonch N; Torrance HL; Dirksen CD
    Hum Reprod; 2016 Nov; 31(11):2527-2540. PubMed ID: 27907897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
    Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
    Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
    Ademi Z; Norman R; Pang J; Liew D; Zoungas S; Sijbrands E; Ference BA; Wiegman A; Watts GF
    Atherosclerosis; 2020 Jul; 304():1-8. PubMed ID: 32526542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany.
    König HH; Barry JC
    Pediatrics; 2004 Feb; 113(2):e95-108. PubMed ID: 14754978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups.
    Al Khayat MNMT; Eijsink JFH; Postma MJ; van de Garde EMW; van Hulst M
    Eur J Health Econ; 2022 Sep; 23(7):1221-1227. PubMed ID: 34985584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of childhood rotavirus vaccination in Germany.
    Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
    Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model.
    Paltiel AD; Fuhlbrigge AL; Kitch BT; Liljas B; Weiss ST; Neumann PJ; Kuntz KM
    J Allergy Clin Immunol; 2001 Jul; 108(1):39-46. PubMed ID: 11447380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis.
    Guzauskas GF; Garbett S; Zhou Z; Schildcrout JS; Graves JA; Williams MS; Hao J; Jones LK; Spencer SJ; Jiang S; Veenstra DL; Peterson JF
    Ann Intern Med; 2023 May; 176(5):585-595. PubMed ID: 37155986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls.
    Ito K
    JAMA Netw Open; 2020 Dec; 3(12):e2027584. PubMed ID: 33258906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis.
    Jalkanen K; Aarnio E; Lavikainen P; Lindström J; Peltonen M; Laatikainen T; Martikainen J
    BMC Health Serv Res; 2021 Sep; 21(1):916. PubMed ID: 34482831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.